In this episode, Don and Steve dig into the evidence behind the most talked-about risks of GLP-1 agonists , separating clinical truth from rumors and headlines
Aim to maintain or increase your exercise routine, focusing on both cardiovascular fitness and strength training
Also acceptable: Plain red
Due to light absorption, exposure to oxygen tension, and high metabolic and energy demands, the retina is an environment highly susceptible to the formation of ROS, including oxidants and free radicals, which damage cellular proteins and lipid membranes 1,2,3,4
Our analysis, based on several FDA trials and observed GLP-1 effects to date, suggests significant reductions in: Musculoskeletal interventions Sleep apnea severity Cardiometabolic complications Need for CPAP equipment Progression to joint replacement surgeries We expect these effects to accelerate in 2026